79389966 - LONZA

Information

  • Trademark
  • 79389966
  • Serial Number
    79389966
  • Filing Date
    October 12, 2023
    a year ago
  • Transaction Date
    November 27, 2024
    2 days ago
  • Status Date
    November 14, 2024
    15 days ago
  • Published for Opposition Date
    December 03, 2024
    3 days from now
  • Location Date
    November 14, 2024
    15 days ago
  • Status Code
    681
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BRADLEY, EVELYN
  • Attorney Docket Number
    5335.155714
    Attorney Name
    Lawrence J. Crain
    Law Office Assigned Location Code
    L40
  • Owners
Mark Drawing Code
5
Mark Identification
LONZA
Case File Statements
  • GS0051: Biological materials for medical and pharmaceutical use, namely, genetically modified cells, genetic material and vectors, namely, cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for medical, clinical and commercial use; human or animal blood, tissue, blood cells and stem-cells for medical, clinical and commercial use; biopharmaceuticals, namely, antibodies and proteins for medical and pharmaceutical use; bioscience products, namely, primary cells, cell cultures and transfection products in the nature of human and animal cells for medical, clinical and commercial use in human and animal therapies; dietary and nutritional supplements; nutritional ingredients in the nature of nutritional supplements as components of dietary regimes and nutritional supplements for medical use in bulk, in the form of tablets, capsules, gel, powder, and liquid or as food additives
  • GS0011: Biological materials, namely, genetically modified cells for scientific and research use; biological tissue in the nature of genetic material and vectors, namely, cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for scientific and pharmaceutical research; biological tissue, namely, human or animal blood, tissue and stem cells for use in scientific and pharmaceutical research; bioconjugates for scientific and pharmaceutical research; bioscience products, being biological tissue in the nature of primary cells, cell cultures and transfection compounds for life-science research; nutritional chemical compounds in bulk powder, tablet, capsule, gel, powder, and liquid form used in the manufacture of dietary and nutritional supplements or food additives; biological preparations, namely, genetically modified cells, genetic material and vectors in the nature of cosmids, plasmids, viral material, or chromosomes for the production of human, animal and synthetic proteins for commercial use, other than for medical or veterinary use; biological preparations for use in industry and science, namely, blood, tissue, blood cells and human or animal stem cells, for commercial use; biological preparations for use in industry and science, namely, bioconjugates for drug development; biological preparations for use in industry and science, namely, primary cells, cell cultures and transfection animal tissue for commercial use in human and animal therapies; biopharmaceutical chemicals, namely, monoclonal antibodies and proteins for scientific and pharmaceutical research
Case File Event Statements
  • 2/27/2024 - 9 months ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/22/2024 - 9 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 2/23/2024 - 9 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/23/2024 - 9 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/18/2024 - 8 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/19/2024 - 8 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/6/2024 - 7 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 4/6/2024 - 7 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 4/15/2024 - 7 months ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/15/2024 - 7 months ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/15/2024 - 7 months ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/1/2024 - 7 months ago
    12 - REFUSAL PROCESSED BY IB Type: RFNT
  • 6/17/2024 - 5 months ago
    13 - ASSIGNED TO LIE Type: ALIE
  • 8/16/2024 - 3 months ago
    15 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/16/2024 - 3 months ago
    14 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/16/2024 - 3 months ago
    16 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/4/2024 - 2 months ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/4/2024 - 2 months ago
    17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/12/2024 - 2 months ago
    20 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 9/12/2024 - 2 months ago
    22 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/9/2024 - 20 days ago
    23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/27/2024 - 2 days ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/4/2024 - 2 months ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/12/2024 - 2 months ago
    21 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA